Vaxart, Inc. (VXRT)
0.4344
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Vaxart Gross Profit Margin (Quarterly) : 97.27% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 97.27% |
| March 31, 2026 | 97.13% |
| December 31, 2025 | 98.03% |
| September 30, 2025 | 97.13% |
| June 30, 2025 | 94.47% |
| March 31, 2025 | 94.73% |
| December 31, 2024 | 92.76% |
| September 30, 2024 | 77.70% |
| June 30, 2024 | 82.82% |
| March 31, 2024 | 49.56% |
| December 31, 2023 | 63.02% |
| September 30, 2023 | 42.88% |
| June 30, 2023 | 17.01% |
| March 31, 2023 | -59.56% |
| December 31, 2022 | -4.30K% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 0.00% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 83.33% |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 94.92% |
| December 31, 2014 | 88.49% |
| September 30, 2014 | -142.9% |
| June 30, 2014 | -4.76% |
| March 31, 2014 | 34.58% |
| December 31, 2013 | 38.38% |
| September 30, 2013 | 7.32% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
| Imunon, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 59.57% |
| Return on Assets | 21.23% |
| Return on Invested Capital | 48.27% |
| Profit Margin (Quarterly) | -49.64% |
| Operating Margin (Quarterly) | -48.45% |
| Return on Net Operating Assets | 42.03% |